iifl-logo

Mankind Pharma Ltd Dividend

2,202.9
(-0.61%)
Dec 3, 2025|03:04:59 PM

Mankind Pharma CORPORATE ACTIONS

18/12/2024calendar-icon
18/12/2025calendar-icon
PurposeAnnouncement DateEx-DateRecord DateDividend AmountDividend per ShareRemark
Dividend31 Jul 20258 Aug 20258 Aug 20251100Interim
approved the payment of interim dividend of ? 1/- per equity share i.e. 100% on face value of ? 1/- per equity share for the Financial Year 2025-26 and in terms of Regulation 42 of the Listing Regulations, Board has fixed Friday, August 8, 2025, as the Record Date for the purpose of ascertaining the eligibility of shareholders for payment of interim dividend. Same would be paid within 30 days from the date of declaration.

Mankind Pharma: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

testing
  • testing
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

testing
  • testing
  • testing

ATTENTION INVESTOR

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.